Nosocomial infections - 6 News

Tip: You can further refine your news selection by organizations and countries.

Nosocomial infections - 6 News

Tip: You can further refine your news selection by organizations and countries.

image description

Calcium Induces Chronic Lung Infections

26-Oct-2016 - The bacterium Pseudomonas aeruginosa is a life-threatening pathogen in hospitals. About ten percent of all nosocomial infections, in particular pneumonia, are caused by this pathogen. Researchers from the University of Basel’s Biozentrum, have now discovered that calcium induces the switch from ...

nosocomial infections antibiotics bacteria
image description

New knowledge about the building blocks of life

06-Sep-2016 - A study of an enzyme that helps build and repair DNA in living organisms increases our understanding of how these processes are controlled and how we can use this to combat infections. Chemists at the Faculty of Science at Lund University in Sweden, together with their colleagues in Umeå and ...

nosocomial infections building blocks enzymes

Intercell starts a pivotal Phase II/III efficacy study with its Pseudomonas aeruginosa vaccine candidate

14-Mar-2012 - Intercell AG announced the start of a pivotal Phase II/III efficacy trial of its investigational Pseudomonas aeruginosa vaccine. The trial follows an exploratory Phase II study in which lower all-cause mortality rates were observed in the vaccine groups as compared to the control group. The Phase ...

nosocomial infections phase III studies vaccines

MorphoSys and Daiichi Sankyo Forge Alliance to Develop Novel Antibody Therapies against Hospital-Acquired Infections

21-Oct-2009 - MorphoSys AG announced the formation of a new alliance with Daiichi Sankyo Company, Limited in the discovery and development of therapeutic antibodies for hospital-acquired (nosocomial) infections. Daiichi Sankyo becomes MorphoSys's first collaborator for HuCAL PLATINUM®-based drug discovery in ...

nosocomial infections education infectious diseases

FAB Pharma raises €2.3 million in series A funding and begins recruitment for a Phase I trial of its lead compound

15-Sep-2009 - FAB Pharma announced the completion of a €2.3 million round of series A funding led by CDC innovation and co-led by Bioam Gestion. The USA-based, healthcare-focused hedge fund Redmile Group also participated in the round. FAB Pharma has acquired assets in the treatment of methicillin-resistant ...

nosocomial infections antibiotics clinical trials

Biophage Pharma announces sale of Immunotox Labs Division to Validapro BioSciences Inc

20-May-2008 - Biophage Pharma announced that it has sold the assets of its Immunotox Labs Division to Validapro BioSciences Inc. for an aggregate consideration of $400,000 in cash and the assumption by Validapro Biosciences of certain liabilities. Validapro BioSciences will maintain all the personnel and will ...

nosocomial infections anti-infectives bacterial infections
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,306 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now